Effectiveness and safety of omalizumab in a patient with chronic urticaria and hepatitis C

E-ISSN： 1468-3083|29|5|1027-1028

ISSN： 0926-9959

Source： JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol.29, Iss.5, 2015-05, pp. : 1027-1028

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effectiveness and safety of ledipasvir plus sofosbuvir in adolescents with chronic hepatitis C virus genotype 4 infection: a real‐world experience

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 6, 2018-03 ,pp. : 838-844

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real‐world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 3, 2018-03 ,pp. : 710-717

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of pediatric chronic spontaneous and physical urticaria patients with omalizumab: case series

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 26, Iss. 6, 2015-09 ,pp. : 585-588

John Wiley & Sons Inc

Access to resources Recommend Favorite

Omalizumab in Chronic Spontaneous Urticaria: A Brazilian Real-Life Experience

International Archives of Allergy and Immunology, Vol. 169, Iss. 2, 2016-04 ,pp. : 121-124

Karger

Access to resources Recommend Favorite

Cost‐effectiveness of sofosbuvir for the treatment of chronic hepatitis C‐infected patients

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 11, 2015-11 ,pp. : 882-889

John Wiley & Sons Inc

Access to resources Recommend Favorite